2013 annual financial data

Theravance Biopharma 2013 Net margin

Theravance Biopharma 2013 net margin with verified reported values.

Direct answer

Net margin was -69,152.21%.

Operating income was -156,284,000 USD and net income was -156,284,000 USD.
Operating cash flow was -120,959,000 USD.

Get free Theravance Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
226,000 USD
Operating income
-156,284,000 USD
Net income
-156,284,000 USD
Operating cash flow
-120,959,000 USD